Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Ontology highlight
SUBMITTER: Pepper AGS
PROVIDER: S-EPMC8727296 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA